Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
labs, supported by certificates of analysis
It helps regulate blood sugar levels by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying, leading to improved glycemic control Mounjaro Tirzepatide 2.5mg Solution for Injection Request Callback 3590 / Vial Get Latest Price Product Brochure Product Name: Mounjaro 2.5mg/5mg Solution for Injection Brand Name: Mounjaro, Tirzepatide, Lyumjev (Note: Lyumjev is primarily insulin lispro, but associated with Eli Lillys diabetes care portfolio) Composition: Tirzepatide (2.5mg/5mg) Manufacturer/Marketer: Eli Lilly and Company India Pvt Ltd Packaging: To be provided (specify packaging details if available) Treatment: Type 2 diabetes mellitus (to improve glycemic control) Product Description: Mounjaro Solution for Injection contains Tirzepatide, a novel dual GIP and GLP-1 receptor agonist used for the management of type 2 diabetes
Its anti-inflammatory and restorative properties help address the root causes of these ailments
We do NOT manufacture this medication and have no direct affiliation with either Eli Lilly and Companyor Novo Nordisk
In contrast, patients on GLP-1 and GIP drugs: Report greater satisfaction with weight loss outcomes Experience fewer cravings and compulsive eating episodes Benefit from once-weekly dosing (vs
